Montelukast Prescribing at THE KEY MEDICAL PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,020
Total Quantity
23.3K
NHS Cost
£1.1K
vs National Avg
+49%
THE KEY MEDICAL PRACTICE prescribed 1,020 items of Montelukast over the last 12 months at a cost of £1,150 to the NHS. This is 49% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
83
Jul 2026
91
Jul 2026
99
Jul 2026
78
Jul 2026
86
Jul 2026
69
Jul 2026
91
Jul 2026
87
Jul 2026
82
Jul 2026
87
Jul 2026
78
Jul 2026
89
Prescribing Details
| Total Items | 1,020 |
|---|---|
| Total Quantity | 23,282 |
| Total NHS Cost | £1,150 |
| Presentations | 3 different forms |
| vs National Average | +49% |
Montelukast Prescribing Comparison
| This practice | 1,020 items |
|---|---|
| National average per practice | 685 items |
| Difference | +49% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.